Ropivacaine in Epidural Pregnancies When it Comes Research Proposal

  • Length: 5 pages
  • Sources: 5
  • Subject: Medicine
  • Type: Research Proposal
  • Paper: #40469991

Excerpt from Research Proposal :

Ropivacaine in Epidural Pregnancies

When it comes time for a woman to have her baby, women worry with the different options and what kind of anesthetic she wants to block the pain during the delivery, who go to the hospital once they start going in to labor, will have already decided that they would like to have an epidural. Therefore, at a certain point in her delivery, the anesthesiologist will be notified, and they will come to the birthing unit room that the mother is in to perform the procedure right there while she is either laying on her side or sitting up while the mother is curled tightly over her belly. This position allows the anesthesiologist to have the best view of her spine so he can make sure that he is putting the needle in between the vertebrae and right outside of the membrane outside the spinal nerves known as the dura in the spine and getting in the epidural lining before the nerve to release the fluid in the needle which will numb the lower half of the woman's body so she does not have to feel any pain through the delivery (American Pregnancy Association).

Epidural anesthesia can differ in the types of medications that hospitals provide but they are all known as local anesthetics, which are either bupivacaine or ropivacaine, and these are usually administered with or without a mixture of opioids or narcotics like fentanyl and sufentanil or morphine to keep from using so much anesthetic when putting the fluids through the IV once the needle inserts the tube in the proper location so that the medicine can flow down in to the spine in to the dura era and numb the body the closer to deliver the mother becomes (American Pregnancy Association). Eventually the epidural can be as powerful as medicine drips down the tube in to the dura area that a woman may not even feel any pain at all when the baby is born and can take a few hours for the feeling to start coming back once the labor and delivery is over.

Anesthesiologists, who are physicians themselves and other scientific experts in this area, are continuously studying the types of medication they used in labor epidural procedures that look at administering medications such as ropivacaine and bupivacaine without the use of any other narcotic pain medication because of precautions and making the delivery of a baby the safest one possible. Furthermore, there have been many comparisons in ropivacaine and bupivacaine for labor epidural analgesia, and ropivacaine is an isomer with a similar molecular set up as bupivacaine, and experts have concluded that not only is ropivacaine less toxic to the central nervous system to delivering mothers and in Cesarean deliveries, as well, with the same amount of ropivacaine and bupivacaine at 0.5% to .25% without having to add a type of narcotic ropivacaine also had a slower commencement and wearing off in a shorter amount of time, too (Merson 54-8). In a recent study of 930 women who delivered received ropivacaine while 917 received bupivacaine with modest disparity in the case of spontaneous vaginal delivery between the anesthetics found in a study completed by Halpern and Walsh (2008).

In Karen McClellan and Diana Faulds look in to ropivacaine in An Update of Its Use in Regional Anesthesia, in 2000 and found that this type of anesthetic guaranteed it was extensive and a untainted amide general sedative with a lofty ionization and small greasy that is soluble which obstructs nerve tissue caught up in pain spread to a better degree than those calculating motor tasks. The medicine is also to be set up as less cardio contaminated than the same exact amount of concentration as bupivacaine; ropivacaine also has a significantly higher threshold for central nervous system (CNS) toxicity than the same degree bupivacaine makes a disparity in groups with better blood absorptions. Further information has been found that reveal that the ropivacaine used in labor epidurals is effective for the initiation and maintenance of labor analgesia, and it also provides pain relief after abdominal or orthopedic surgical procedures even without adding opioids and other forms of narcotics. Furthermore, their findings are also the same that there is a smaller amount motor of barriers in minor concentrations when ropivacaine is used over bupivacaine (2000).

McClellan and Faulds also found that ropivacaine over bupivacaine was very similar yet it reversibly wedges nerve impulse conveyance by decreasing nerve chamber covering permeability to sodium ions. In learning about these comparisons it has also been revealed that, because of its ionization make up and little dissolve the medicine gives preference in keeping nerve fibers from being dependable for pain diffusion rather than motor skills of patients. These two experts include in their work that ropivacaine has a biphasic vascular outcome; therefore, it causes vasoconstriction at low focuses but not at advanced ones (1065=1093).

Ropivacaine, at 0.2% offered sufficient pain relief when applied from the beginning between 10 to 18ml throughout labor and its effectiveness usually is comparable to that of the same quantity of bupivacaine with consideration to pain release and motor obstruction with no noteworthy effect on neonatal consequences. Furthermore, using ropivacaine around the 0.2% infused at 10ml for periods of almost 24 hours, even after Caesareans, reduced morphine necessities. Even though the ropivacaine, is more effective on pain when narcotics are added, but more is being done to keep pregnancies safer with using less narcotics and higher concentrations of the ropivacaine even over bupivacaine (McClellan, and Faulds 1065-1093).

Recently, by McClellan and Faulds, they administered ropivacaine and not adding any narcotics in addition to 0.1% of the medication which resulted to not give ample pain assistance in order to initiate an epidural for labor and delivery. Yet in a recent study that was conducted, in figure 1 & 2 below which showed that "0.125% ropivacaine and 2ml of fentanyl with 0.125% bupivacaine and 2ml fentanyl, showed that ropivacaine mixed offered labor analgesia that was clinically indistinguishable from the bupivacaine mix but with less motor block. In the second study, 2ml of fentanyl was added to reduce the ropivacaine requirements during labor by 28% (McClellan, and Faulds 1065-1093).

More hospitals' labor and delivery units that were using epidural analgesia of dosages of bupivacaine as their primary option have been converting over to ropivacaine according to an article of the Mode of Delivery Following Labor Epidural Analgesia: Influence of Ropivacaine and Bupivacaine wrote by Alexander A. Litwin who did a study out of Orlando Florida. Litwin found that in records of 500 consecutive patients that received different types of medication either as ropivacaine and bupivacaine for their epidurals in labor. The patients did not differ demographically, yet the patients that received bupivacaine with and without fentanyl required additional analgesia than patients with the ropivacaine or with it mixed with another medication during labor (Litwin, 259-260).

A chief concerns with pregnant women who go in to labor and use local anesthetics is the fact that millions each year are in higher elevations which can affect newborns and their mothers. There were a total of 68 women who either took ropivacaine or bupivacaine n=34, so both groups were equal. The Arab women of both groups had similar labor characteristics, obstetric results, with similar heart rates and blood pressures with results with no important dissimilarities in regards their infants' birth weights, respiratory distress, blood gases, as well as abnormal arterial blood gases with living in the higher elevations after being administered bupivacaine or ropivacaine which affected the children being monitored longer or mainly within the first 30 days of their lives once they were born. Found by doctors at Assiut University in Assiut, Egypt, was because of how these medications can cause additional complications because of the fetal…

Online Sources Used in Document:

Cite This Research Proposal:

"Ropivacaine In Epidural Pregnancies When It Comes" (2011, July 17) Retrieved January 23, 2017, from

"Ropivacaine In Epidural Pregnancies When It Comes" 17 July 2011. Web.23 January. 2017. <>

"Ropivacaine In Epidural Pregnancies When It Comes", 17 July 2011, Accessed.23 January. 2017,